Innovation Pharmaceuticals Inc (IPIX)

[Patientspeople]

FOX Business, Innovation's Brilacidin was acknowledged today, getting mentioned, getting attention on a short list of possibilities. The citied Source: WHO, FDA news reports.

Brilacidin is earning more attention because it's progressing thru RBL trials virtually free of charge, who would've imagined this a few months ago. In life, timing is everything. While we all hate what this virus has done to wreak havoc to mankind around the world, it is a cause of celebration to see it eliminated ASAP. Brilacidin could be a very effective single agent against COVID-19 when the dust settles or a very important combo agent.

If Brilacidin continues to show strong efficacy & safety in the more advanced trials at the RBL's, it will ultimately overcome all the doubters and dumpers and get the attention for partnership or a buyout. Shrewd big pharma/biotech who see and jump on the opportunity after successful RBL clinical trials against COVID-19 to include B-OM, B-IBD and also get Kevetrin would be very attractive... the stock will soar and could be the stock investment of the year!!!

Gilead's Remdesivir recent data (yesterday) is good progress as a single agent, not a home run, the death rate is not a great improvement vs. placebo... Maybe a Remdesivir and Brilacidin combo possibility in the future?